Literature DB >> 21879256

State of heat shock factor 1 expression as a putative diagnostic marker for oral squamous cell carcinoma.

Junya Ishiwata1, Atsushi Kasamatsu, Kentaro Sakuma, Manabu Iyoda, Masanobu Yamatoji, Katsuya Usukura, Shunsaku Ishige, Toshihiro Shimizu, Yukio Yamano, Katsunori Ogawara, Masashi Shiiba, Hideki Tanzawa, Katsuhiro Uzawa.   

Abstract

Heat shock factor 1 (HSF1) is responsible for expres-- sion of a large class of heat shock proteins that have been implicated in the malignant phenotype of human cancers. Little is known about the effect of a high level of HSF1 on the behavior of oral squamous cell carcinoma (OSCC). In this study, we assessed the value of HSF1 for predicting clinical outcomes in OSCC. Quantitative reverse transcriptase-polymerase chain reaction and Western blotting showed that the expressions of HSF1 mRNA and protein in OSCC-derived cell lines (HSC-2, HSC-3, HSC-4, Sa3, Ca9-22, KON and Ho-1-u-1) were elevated compared with those in human normal oral keratinocytes (P<0.05). Similar to in vitro data, HSF1 mRNA expression in primary OSCCs (n=50) was significantly greater than in normal counterparts (P<0.05). Since HSF1 was observed in the nucleus and cytoplasm by immu-- nohistochemistry, we investigated the correlation between the HSF1 expression status at each subcellular location and the clinical behavior of OSCCs. Among the clinical classifications, higher nuclear HSF1 expression was closely related to tumor size and histopathologic types (P<0.05). These results showed for the first time that nuclear HSF1 expression may contribute to cancer progression and that HSF1 might be a potential diagnostic biomarker and a therapeutic target for OSCCs.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21879256     DOI: 10.3892/ijo.2011.1178

Source DB:  PubMed          Journal:  Int J Oncol        ISSN: 1019-6439            Impact factor:   5.650


  25 in total

1.  MicroRNA-615-5p regulates the proliferation and apoptosis of breast cancer cells by targeting HSF1.

Authors:  Kaisheng Liu; Rong Ma
Journal:  Exp Ther Med       Date:  2021-01-07       Impact factor: 2.447

2.  HSF1, a versatile factor in tumorogenesis.

Authors:  S K Calderwood
Journal:  Curr Mol Med       Date:  2012-11-01       Impact factor: 2.222

Review 3.  Proteotoxic stress of cancer: implication of the heat-shock response in oncogenesis.

Authors:  Chengkai Dai; Siyuan Dai; Junyue Cao
Journal:  J Cell Physiol       Date:  2012-08       Impact factor: 6.384

Review 4.  Multifaceted roles of HSF1 in cancer.

Authors:  Sufang Jiang; Kailing Tu; Qiang Fu; David C Schmitt; Lan Zhou; Na Lu; Yuhua Zhao
Journal:  Tumour Biol       Date:  2015-06-25

Review 5.  HSF1: Guardian of Proteostasis in Cancer.

Authors:  Chengkai Dai; Stephen Byers Sampson
Journal:  Trends Cell Biol       Date:  2015-11-18       Impact factor: 20.808

Review 6.  HSF1 as a Cancer Biomarker and Therapeutic Target.

Authors:  Richard L Carpenter; Yesim Gökmen-Polar
Journal:  Curr Cancer Drug Targets       Date:  2019       Impact factor: 3.428

7.  NRF2 transcriptionally activates the heat shock factor 1 promoter under oxidative stress and affects survival and migration potential of MCF7 cells.

Authors:  Soumyadip Paul; Suvranil Ghosh; Sukhendu Mandal; Subrata Sau; Mahadeb Pal
Journal:  J Biol Chem       Date:  2018-10-11       Impact factor: 5.157

8.  Overexpression of CDCA2 in human squamous cell carcinoma: correlation with prevention of G1 phase arrest and apoptosis.

Authors:  Fumihiko Uchida; Katsuhiro Uzawa; Atsushi Kasamatsu; Hiroaki Takatori; Yosuke Sakamoto; Katsunori Ogawara; Masashi Shiiba; Hiroki Bukawa; Hideki Tanzawa
Journal:  PLoS One       Date:  2013-02-13       Impact factor: 3.240

9.  HSF1 Is Essential for Myeloma Cell Survival and A Promising Therapeutic Target.

Authors:  Jacqueline H L Fok; Somaieh Hedayat; Lei Zhang; Lauren I Aronson; Fabio Mirabella; Charlotte Pawlyn; Michael D Bright; Christopher P Wardell; Jonathan J Keats; Emmanuel De Billy; Carl S Rye; Nicola E A Chessum; Keith Jones; Gareth J Morgan; Suzanne A Eccles; Paul Workman; Faith E Davies
Journal:  Clin Cancer Res       Date:  2018-02-01       Impact factor: 12.531

10.  Overexpression of cell cycle regulator CDCA3 promotes oral cancer progression by enhancing cell proliferation with prevention of G1 phase arrest.

Authors:  Fumihiko Uchida; Katsuhiro Uzawa; Atsushi Kasamatsu; Hiroaki Takatori; Yosuke Sakamoto; Katsunori Ogawara; Masashi Shiiba; Hideki Tanzawa; Hiroki Bukawa
Journal:  BMC Cancer       Date:  2012-07-28       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.